2015
DOI: 10.1158/1535-7163.mct-14-1048
|View full text |Cite
|
Sign up to set email alerts
|

Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells

Abstract: Cambogin is a polycyclic polyprenylated acylphoroglucinol (PPAP) from the Garcinia genus, which has been used traditionally for cancer treatment across Southeastern Asia. In this study, we found that cambogin inhibited breast cancer cell proliferation and induced cell apoptosis in vitro. Cambogin induced the activation of the caspase-independent mitochondrial apoptotic pathway, as indicated by an increase in the ratio of Bax/Bcl-2 and the nuclear translocation of apoptosis inducing factor (AIF). Two-dimensiona… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
33
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 38 publications
(37 citation statements)
references
References 42 publications
(53 reference statements)
3
33
0
Order By: Relevance
“…We have reported previously [21] that cambogin (chemical structure shown in Figure 1A) strongly inhibits cell proliferation in several breast cancer cell lines, including MCF-7 (ER + PR + HER2 − ), SK-BR-3 (ER − PR − HER2 + ) and MDA-MB-468 (ER − PR − HER2 − , also known as TNBC (triple negative breast cancer)). As shown in Figure 1B, cambogin (0-10 μM) treatment led to a reduction in MCF-7 cell viability in a dose-dependent manner, which can be achieved with a concentration as low as 1.25 μM, whereas at 10 μM it produced the maximal inhibition.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…We have reported previously [21] that cambogin (chemical structure shown in Figure 1A) strongly inhibits cell proliferation in several breast cancer cell lines, including MCF-7 (ER + PR + HER2 − ), SK-BR-3 (ER − PR − HER2 + ) and MDA-MB-468 (ER − PR − HER2 − , also known as TNBC (triple negative breast cancer)). As shown in Figure 1B, cambogin (0-10 μM) treatment led to a reduction in MCF-7 cell viability in a dose-dependent manner, which can be achieved with a concentration as low as 1.25 μM, whereas at 10 μM it produced the maximal inhibition.…”
Section: Resultsmentioning
confidence: 99%
“…Polycyclic polyprenylated acylphloroglucinols (PPAPs), one of the main bioactive components, are known to possess anticancer activities, including the induction of apoptosis, the inhibition of proliferation, and the prevention of cancer metastasis and tumor angiogenesis [19-21]. One of the mechanisms by which PPAPs exert anti-tumor effect is via elevating the levels of ROS [21, 22]. Cambogin is a bioactive PPAP isolated from the branches of Garcinia esculenta [23].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Colony formation assay was performed as described previously (25). Tumor cells were seeded into 6-well plates and cultured overnight.…”
Section: Colony Formation Assaymentioning
confidence: 99%
“…It is well known that ROS generation is closely associated with early stages of apoptosis and mitochondrial dysfunction (36). Earlier reports suggest that ROS generation, together with Cyt C release from mitochondria, promote cell death (37, 38). This results in increased permeability of the outer mitochondrial membrane, decreasing transmembrane potential, and activation of AIF (32) eventually inducing caspase-independent apoptosis (39).…”
Section: Discussionmentioning
confidence: 99%